NT-501

· Neurotech Pharmaceuticals

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for NT-501, covering 2024-09-24 to 2026-04-03. Get the full timeline:

Most recent: Clinical Trial Update: Phase 4 Study: Long-term Safety and Efficacy of NT-501 in MacTel Type 2, Including Sham Procedure Participants [Phase 4]

See pricing